Evidence map›Paper›PMID 29151594›Full record

ArticleInternational journal of obesity (2005)2018

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.

C Carbone, G Piro, N Gaianigo, F Ligorio, R Santoro, V Merz, F Simionato, C Zecchetto, G Falco, G Conti and 7 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

C CarboneDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.
G PiroDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.
N GaianigoDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.
F LigorioDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.
R SantoroDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.
V MerzMedical Oncology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
F SimionatoMedical Oncology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
C ZecchettoMedical Oncology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
G FalcoDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
G ContiNeusosciences Biomedicine and Movement Department, Anatomy and Histology Division, University of Verona, Verona, Italy.
P T KamgaSection of Hematology, Department of Medicine, Università Degli Studi di Verona, Verona, Italy.
M KramperaSection of Hematology, Department of Medicine, Università Degli Studi di Verona, Verona, Italy.
F Di NicolantonioDepartment of Oncology, University of Torino, Candiolo, Italy.ORCID 0000-0001-9618-2010
L De FranceschiDepartment of Medicine, University of Verona-AOUI Verona, Verona, Italy.
A ScarpaARC-Net Research Centre and Department of Pathology and Diagnostics, University of Verona, Verona, Italy.
G TortoraLaboratory of Oncology and Molecular Therapy, Department of Medicine, University of Verona, Verona, Italy.
D MelisiDigestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, Verona, Italy.ORCID 0000-0002-4031-7585
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · ITCandiolo Cancer Institute · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSolid epidemiological evidences connect obesity with incidence, stage and survival in pancreatic cancer. However, the underlying mechanistic basis linking adipocytes to pancreatic cancer progression remain largely elusive. We hypothesized that factors secreted by adipocytes could be responsible for epithelial-to-mesenchymal transition (EMT) induction and, in turn, a more aggressive phenotype in models of pancreatic preneoplastic lesions.

methodsWe studied the role of factors secreted by two adipogenic model systems from primary human bone marrow stromal cells (hBMSCs) in an in vitro experimental cell transformation model system of human pancreatic ductal epithelial (HPDE) cell stably expressing activated KRAS (HPDE/KRAS),Results:We measured a significant induction of EMT and aggressiveness in HPDE and HPDE/KRAS cell lines when cultured with medium conditioned by fully differentiated adipocytes (ADIPO

conclusionsWe demonstrated that adipocytes could induce EMT and aggressiveness in models of pancreatic preneoplastic lesions by orchestrating a complex paracrine signaling of soluble modulators of the non-canonical WNT signaling pathway that determine, in turn, the activation and nuclear translocation of ROR2. This signaling pathway could represent a novel target for pancreatic cancer chemoprevention. Most importantly, these factors could serve as novel biomarkers to select a risk population among obese subjects for screening and, thus, early diagnosis of pancreatic cancer.

Indexed as

AdipocytesCell LineCell NucleusEpithelial-Mesenchymal TransitionHumansMesenchymal Stem CellsModels, BiologicalPancreatic NeoplasmsReceptor Tyrosine Kinase-like Orphan ReceptorsSignal TransductionWnt ProteinsReceptor Tyrosine Kinase-like Orphan ReceptorsROR2 protein, humanWnt Proteins

Identifiers

PMID29151594
PMCPMC5880584
OpenAlexW2769840370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.